285 related articles for article (PubMed ID: 32339497)
21. Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models.
Chen T; Yamamoto S; Kitano M; Murai T; Wanibuchi H; Matsukuma S; Nakatsuru Y; Ishikawa T; Fukushima S
Teratog Carcinog Mutagen; 1998; 18(3):101-10. PubMed ID: 9728794
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.
Koll FJ; Metzger E; Hamann J; Ramos-Triguero A; Bankov K; Köllermann J; Döring C; Chun FKH; Schüle R; Wild PJ; Reis H
Cells; 2023 Feb; 12(4):. PubMed ID: 36831256
[TBL] [Abstract][Full Text] [Related]
23. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
24. mRNA-Expression of
Eckstein M; Wirtz RM; Gross-Weege M; Breyer J; Otto W; Stoehr R; Sikic D; Keck B; Eidt S; Burger M; Bolenz C; Nitschke K; Porubsky S; Hartmann A; Erben P
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380731
[TBL] [Abstract][Full Text] [Related]
25.
Kobatake K; Ikeda KI; Nakata Y; Yamasaki N; Ueda T; Kanai A; Sentani K; Sera Y; Hayashi T; Koizumi M; Miyakawa Y; Inaba T; Sotomaru Y; Kaminuma O; Ichinohe T; Honda ZI; Yasui W; Horie S; Black PC; Matsubara A; Honda H
Clin Cancer Res; 2020 Apr; 26(8):2065-2079. PubMed ID: 32047002
[TBL] [Abstract][Full Text] [Related]
26. Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation.
Li T; Huang M; Sun N; Hua X; Chen R; Xie Q; Huang S; Du M; Zhao Y; Lin Q; Xu J; Han X; Zhao Y; Tian Z; Zhang Y; Chen W; Shen X; Huang C
J Exp Clin Cancer Res; 2024 Feb; 43(1):50. PubMed ID: 38365726
[TBL] [Abstract][Full Text] [Related]
27. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
29. Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20.
Jangir H; Nambirajan A; Seth A; Sahoo RK; Dinda AK; Nayak B; Kaushal S
Ann Diagn Pathol; 2019 Dec; 43():151397. PubMed ID: 31494492
[TBL] [Abstract][Full Text] [Related]
30. [Preneoplastic lesions and precursors of urothelial cancer].
Knüchel-Clarke R; Gaisa NT
Pathologe; 2016 Feb; 37(1):33-9. PubMed ID: 26811248
[TBL] [Abstract][Full Text] [Related]
31. Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.
Fontugne J; Wong J; Cabel L; Neyret-Kahn H; Karboul N; Maillé P; Rapinat A; Gentien D; Nicolas A; Baulande S; Sibony M; Bernard-Pierrot I; Radvanyi F; Allory Y
J Pathol; 2023 Apr; 259(4):455-467. PubMed ID: 36695554
[TBL] [Abstract][Full Text] [Related]
32. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
[TBL] [Abstract][Full Text] [Related]
33. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
34. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
[TBL] [Abstract][Full Text] [Related]
35. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
[TBL] [Abstract][Full Text] [Related]
36. Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer.
He F; Zhang F; Liao Y; Tang MS; Wu XR
Cancer Lett; 2022 Dec; 550():215924. PubMed ID: 36195293
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.
Sanchez-Carbayo M; Socci ND; Charytonowicz E; Lu M; Prystowsky M; Childs G; Cordon-Cardo C
Cancer Res; 2002 Dec; 62(23):6973-80. PubMed ID: 12460915
[TBL] [Abstract][Full Text] [Related]
38. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M
Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
